Nexpoint Asset Management’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Nexpoint Asset Management’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-125,000	Closed	-$5.75K	–	124
2023 Q1	$5.75K	Hold	125,000	–	–	﹤0.01%	96
2022 Q4	$1.34K	Hold	125,000	–	–	﹤0.01%	124
2022 Q3	$11K	Hold	125,000	–	–	﹤0.01%	135
2022 Q2	$16K	Hold	125,000	–	–	﹤0.01%	137
2022 Q1	$35K	Hold	125,000	–	–	﹤0.01%	150
2021 Q4	$0	Buy	+125,000	New	+$62.8K	﹤0.01%	254

Nexpoint Asset Management's IQMDW Position: Q2 2023 in Review

Nexpoint Asset Management sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 125,000 shares — an estimated $5.75K sold.

Nexpoint Asset Management first reported a position in IQMDW in Q4 2021 and held it in 6 quarters. The position peaked at $35K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Nexpoint Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Nexpoint Asset Management sold 125,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $5.75K.
Nexpoint Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2021 and held it in 6 quarters.
Nexpoint Asset Management's Intelligent Medicine Acquisition Corp. Warrant position peaked at $35K in Q1 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Nexpoint Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.